| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Japan | 3 | |
| #2 | Australia | 1 | |
| #3 | China | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Hong Kong | 1 | |
| #6 | Hungary | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | New Zealand | 1 | |
| #11 | Serbia | 1 | |
| #12 | Singapore | 1 | |
| #13 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vadas Elizabeth | 11 |
| #2 | Goldsmith Mark A | 9 |
| #3 | Goldsmith Mark | 2 |
| #4 | Elizabeth Vadas | 1 |
| #5 | Mark A Goldsmith | 1 |
| #6 | Vadas Elizabeth B | 1 |
| #7 | Mark Goldsmith | 1 |
| #8 | Elizabeth B Vadas | 1 |
| #9 | Goldsmith Mark A A | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2010047756A1 | Oral dosage forms including an antiplatelet agents and an enterically coated acid inhibitor | |
| NZ610147A | Oral dosage forms including an antiplatelet agent and an acid inhibitor | |
| AU2007234398A1 | Oral dosage forms including an antiplatelet agent and an acid inhibitor |